Group by Gene: Include preclinical: Tyrosine Kinase Inhibitors Serine-Threonine Kinase Inhibitors Epigenetics Other Threonine-Tyrosine Kinase Inhibitors | mTOR inhibitor temsirolimus | everolimus | PRMT5 inhibitor MRTX1719 | BRAF inhibitor, BRAF V600E inhibitor vemurafenib | TrkB receptor inhibitor, TrkC kinase inhibitor, ROS1 inhibitor, TrkA receptor inhibitor, ALK inhibitor, JAK2 inhibitor, TNK2 inhibitor entrectinib | ALK inhibitor crizotinib | Glutamine antagonist, Nerve growth factor inhibitor DR6MP + JHU395 | Nerve growth factor inhibitor DR6MP | WEE1 inhibitor AZD1775 | c-MET inhibitor, MEK inhibitor MEK inhibitor + c-MET inhibitor |
---|---|---|---|---|---|---|---|---|---|---|
NF2 E108X | ||||||||||
NF1 mutation + CDKN2A deletion + CDKN2B deletion + MTAP deletion | ||||||||||
NTRK3 fusion | ||||||||||
BRAF V600E | ||||||||||
NTRK1 fusion | ||||||||||
NF1 mutation | ||||||||||
TP53 mutation | ||||||||||
TSC2 A736V | ||||||||||
TJP1-ROS1 fusion + NF1 mutation |